Back
Day Range
$73.12
$74.68
52-Week Range
$71.55
$99.20
Volume
1,019,799
50D / 200D Avg
$80.51
/
$80.90
Prev Close
$74.14
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 36.9 | 0.3 |
| P/B | 1.6 | 2.9 |
| ROE % | 4.5 | 3.7 |
| Net Margin % | 9.4 | 3.8 |
| Rev Growth 5Y % | 5.8 | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$91.02
+22.6%
Low: $80.00
High: $101.09
Forward P/E
22.1
Forward EPS
$3.36
EPS Growth (est.)
+0.0%
Est. Revenue
11 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$5.56
$5.46 – $5.68
|
14 B | 5 |
| FY2029 |
$4.97
$4.87 – $5.07
|
13 B | 10 |
| FY2028 |
$4.37
$2.91 – $5.43
|
12 B | 12 |
Key Takeaways
Revenue grew 5.83% annually over 5 years — modest growth
ROE of 4.50% is below average
Debt/Equity of 0.24 — conservative balance sheet
Generating 1.73B in free cash flow
P/E of 36.93 — premium valuation
Cash machine — converts 176.33% of earnings into free cash flow
Growth
Revenue Growth (5Y)
5.83%
Revenue (1Y)4.94%
Earnings (1Y)-3.73%
FCF Growth (3Y)79.38%
Quality
Return on Equity
4.50%
ROIC3.74%
Net Margin9.42%
Op. Margin13.08%
Safety
Debt / Equity
0.24
Current Ratio2.12
Interest Coverage0.00
Valuation
P/E Ratio
36.93
P/B Ratio1.64
EV/EBITDA29.34
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.94% | Revenue Growth (3Y) | 4.88% |
| Earnings Growth (1Y) | -3.73% | Earnings Growth (3Y) | 0.31% |
| Revenue Growth (5Y) | 5.83% | Earnings Growth (5Y) | 27.06% |
| Profitability | |||
| Revenue (TTM) | 10.40B | Net Income (TTM) | 980.00M |
| ROE | 4.50% | ROA | 3.11% |
| Gross Margin | 55.24% | Operating Margin | 13.08% |
| Net Margin | 9.42% | Free Cash Flow (TTM) | 1.73B |
| ROIC | 3.74% | FCF Growth (3Y) | 79.38% |
| Safety | |||
| Debt / Equity | 0.24 | Current Ratio | 2.12 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 36.93 | P/B Ratio | 1.64 |
| P/S Ratio | 3.48 | PEG Ratio | -11.71 |
| EV/EBITDA | 29.34 | Dividend Yield | 0.00% |
| Market Cap | 36.19B | Enterprise Value | 39.91B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10.40B | 9.91B | 9.46B | 8.72B | 8.29B |
| Net Income | 980.00M | 1.02B | 974.00M | 335.00M | 376.00M |
| EPS (Diluted) | 1.98 | 2.05 | 1.96 | 0.68 | 0.76 |
| Gross Profit | 5.75B | 5.51B | 5.25B | 4.75B | 4.65B |
| Operating Income | 1.36B | 1.41B | 1.04B | 672.00M | 580.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 31.56B | 30.35B | 29.61B | 29.21B | 28.00B |
| Total Liabilities | 9.52B | 8.79B | 8.99B | 9.53B | 8.74B |
| Shareholders' Equity | 22.03B | 21.55B | 20.62B | 19.68B | 19.26B |
| Total Debt | 5.25B | 5.14B | 5.14B | 5.07B | 4.48B |
| Cash & Equivalents | 1.53B | 1.68B | 1.09B | 980.00M | 1.58B |
| Current Assets | 6.45B | 6.31B | 5.65B | 5.19B | 5.39B |
| Current Liabilities | 3.05B | 2.28B | 2.40B | 2.74B | 2.47B |